Class IICompleted

Adrenalin (epinephrine) Injection 1mg/mL recall

FDA recall D-0342-2024 · initiated Jan 17, 2024

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date. The expiration date listed on the Repack Pouch Label is incorrect.

Details

Product: Adrenalin (epinephrine) Injection 1mg/mL, 1mL single dose vial, Rx only, Packaged By: Henry Schein, Inc., 80 Summit View Lane, Bastian, VA 24314, Original NDC 42023-159-25 Repack NDC 0404-9810-01
Recalling company: Henry Schein Inc. and Glove Club HSI Gloves Inc.
Classification: Class II
Status: Completed
Type: Voluntary: Firm initiated
Distribution: USA nationwide.
Initiated: Jan 17, 2024
FDA report date: Feb 28, 2024

This recall is linked to a product we cover: Adrenalin →

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0342-2024 ↗

← All drug recalls